1[1]Day C P.Non - alcoholic steatohepatitis (NASH): Where are we now and where are we going? Gut,2002;50:585 ～ 58
2[2]Shiva Kumar K, Peter F Malet. Nonalcoholic steatohepatitis. Mayo Clinic Pro ceedings, 2000; 75: 73 ～ 79
3[3]Valenti L, Fracanzani AL, Dongiovanni P, et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver dis ease. Gastroenterology, 2002; 122(2): 274 ～ 80
4[4]Graham Robertson, Isabelle Ieclercq, Geoffrey C Farrell. Nonalcoholic steatosis and steatohepatitis II. Cytochmme P - 450 enzymes and oxidative stress American Journal of Physiology. 2001 ;44:G1135 ～ G1139
5[5]Seki S, Kitada T, Yamada T, et al. In situ detection of lipid peroxidation and oxidative DNA damage in non - alcoholic fatty liver diseases. J Hepatol, 2002;37(1) :56～ 62
6[6]Tankurt E, Biberoglu S, Ellidokuz E, et al. Hyperinsulinemia and insulinresistance in non - alcoholic steatohepatitis [letter]. J Hepatol. 1999;31:963
7[7]Riordan S M, Duncombe V M, Thomas M C, et al . Small intestinal bacterial overgrowth, intestinal permeability, and non - alcoholic steatohepatitis / Author's reply. Gut, 2002;50:136 ～ 38
8[8]Tokita H, Murai S, Kamitsukasa H, et al. Influence of TI virus on the histopathological features of nonalcoholic fatty liver disease. Hepatol Res, 2001; 19(3): 197 ～ 211
9[9]0kamoto Y, Tanaka S, Haga Y. Enhanced GLUT2 gene expression in an oleic acid - induced in vitro fatty liver model. Hepatol Res, 2002; 23(2): 138 ～ 144
10[10]Inui Y, Keno Y, Fukuda K, et al. Modulation of apolipoprotein gene ex pression in fatty liver of obese rats: enhanced APOA - 1V, but no APOB expression by a high sucrose diet. Int J Obes Relat Metab Disord , 1997;21 (3) :231 ～ 238
